Mettler-Toledo International (MTD) is a publicly traded Healthcare sector company. As of May 21, 2026, MTD trades at $1,084.86 with a market cap of $21.72B and a P/E ratio of 25.35. MTD moved +2.96% today. Year to date, MTD is -25.16%; over the trailing twelve months it is -8.71%. Its 52-week range spans $946.69 to $1,525.17. Analyst consensus is buy with an average price target of $1,349.69. Rallies surfaces MTD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Mettler-Toledo Posts Q1 EPS Growth but Stock Lags Peers Friday: Mettler-Toledo International reported year-over-year Q1 2026 adjusted EPS growth and a revenue increase, reaffirming its full-year guidance. Despite robust results, its stock underperformed industry peers on Friday’s session amid sector rotation.
| Metric | Value |
|---|---|
| Price | $1,084.86 |
| Market Cap | $21.72B |
| P/E Ratio | 25.35 |
| EPS | $42.70 |
| Dividend Yield | 0.00% |
| 52-Week High | $1,525.17 |
| 52-Week Low | $946.69 |
| Volume | 5 |
| Avg Volume | 0 |
| Revenue (TTM) | $4.09B |
| Net Income | $875.06M |
| Gross Margin | 59.19% |
9 analysts cover MTD: 0 strong buy, 5 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $1,349.69.